Genzyme (Sanofi)
Cambridge, MA (division of Sanofi, HQ: Paris, France)
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (10)
○ EMA GMP
○ MHRA GMP
Quick Facts: Genzyme (Sanofi)
- Signal Score
- 60.0/100
- Quality Compliance
- Assessment pending
- Headquarters
- Cambridge, MA (division of Sanofi, HQ: Paris, France)
- Modalities
- Biologics, Rare Disease Therapeutics, Gene Therapy (legacy), Sterile Injectables, Enzyme Replacement Therapy
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Genzyme (Sanofi)
Auto-created by AI matchmaker. Data verification pending.
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesBiologics, Rare Disease Therapeutics, Gene Therapy (legacy), Sterile Injectables, Enzyme Replacement Therapy
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
60.0
Broad modality coverage (5 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Recent Press10 articles
Broad modality coverage (5 modalities)
Recent News 10 articles
Sanofi scores FDA nod for $270K nanobody drug Cablivi, its first from the Ablynx deal - Fierce Pharma
Sanofi leases its soon-to-be-former Genzyme HQ to Bluebird Bio—at a profit - Fierce Pharma
Fabrazyme litigation back in play for Sanofi's Genzyme as appeals court overturns dismissal of 2020 lawsuit - Fierce Pharma
Sanofi quits Voyager gene therapy deal once worth up to $845M - Fierce Biotech
Sanofi recalls arthritis injection that is tied to microbial contamination - Fierce Pharma
MJFF Sponsors Phase Ib Trial with Sanofi’s Parkinson Disease Candidate - genengnews.com
Screening data from 19 patients with late-onset Pompe disease for a phase I clinical trial of AAV8 vector-mediated gene therapy - Wiley Online Library
Eleven years after buying Genzyme, Sanofi officially ditches subsidiary’s storied name - STAT
National Resilience takes over Genzyme/Sanofi building in Allston - Harvard Gazette
Sanofi eyes big Cambridge, Massachusetts, expansion for fast-growing Genzyme business: report - Fierce Pharma
Frequently Asked Questions About Genzyme (Sanofi)
What is Genzyme (Sanofi)'s CDMO Signal Score?
Genzyme (Sanofi) has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.
Evaluating Genzyme (Sanofi) for a manufacturing program?
Use the free AI matchmaker to compare Genzyme (Sanofi) against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Abzena
San Diego, CA; Bristol, PA; Cambridge, UK
Signal Score: 64.0
ADC, AOC, RDC, PDC, DAC, Fusion Proteins, Bispecifics, bsAbs, Multispecifics, msAbs, Bioconjugates, Biologics, mAb, Monoclonal Antibody, Antibodies, Cytokines, HPAPI, Bioconjugation
Sanofi (Genzyme / Sanofi Manufacturing)
Paris, France
Biologics, Monoclonal Antibody, Recombinant Protein, API (small molecule and biologic), Vaccines, Sterile Fill-Finish, Cell Therapy (internal)
Pfizer CentreOne
Kalamazoo, MI · McPherson, KS
Signal Score: 91.5
Biologics, mRNA
Ajinomoto Bio-Pharma Services
San Diego, CA · Osaka, JP
Signal Score: 85.6
Oligonucleotide, Biologics, AAV
Lotte Biologics
Incheon, KR · Syracuse, NY
Signal Score: 83.7
Biologics, AAV